[CAS NO. 170277-31-3] Infliximab

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [170277-31-3]

Catalog

HY-P9970

Brand

MCE

CAS

170277-31-3

DESCRIPTION [170277-31-3]

Overview

MDL	-
Molecular Weight	-
Molecular Formula	Unspecified
SMILES	[Avakine]

For research use only. We do not sell to patients.

2 Publications Citing Use of MCE

Summary

Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α . Infliximab prevents the interaction of TNF-α with TNF-α receptor (TNFR1 and TNFR2). Infliximab has the potential for autoimmune, chronic inflammatory diseases and diabetic neuropathy research ^[1] ^[2] .

In Vitro

TNF-α-treated adipocytes shows a significant 64% decrease in insulin-stimulated glucose uptake, whereas Infliximab (10 ng/mL) reverses TNF-α actions by significantly improving glucose incorporation in 3T3L1 adipocytes. Infliximab restores phosphorylation of substrate-2 and AKT by attenuating protein-tyrosine phosphatase 1B (PTP1B) activation. Infliximab ameliorates TNF-α-induced insulin resistance in 3T3L1 adipocytes in vitro by restoring the insulin signalling pathway via PTP1B inhibition ^[1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

A single injection of Infliximab (10 μg/g in 100 μl saline/dose ip) in diabetic TNF-α ^+/+ ) mice leads to suppression of the increased serum TNF-α and amelioration of the electrophysiological and biochemical deficits for at least 4 weeks. The increased TNF-α mRNA expression in diabetic dorsal root ganglion is also attenuated by Infliximab ^[2] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase
NCT00606346	Janssen Biotech, Inc.	Crohn´s Disease\|Ulcerative Colitis\|Indeterminate Colitis\|Inflammatory Bowel Diseases	May 31, 2007
NCT02332356	Tokyo Medical and Dental University	Crohn Disease	September 2014	Phase 3
NCT04178850	Genor Biopharma Co., Ltd.	Rheumatoid Arthritis	October 13, 2017	Phase 3
NCT02620618	Cairo University	Behçet´s Disease\|Uveitis	January 2013	Phase 1\|Phase 2
NCT00207675	Centocor, Inc.\|Centocor BV	Crohn Disease	February 2003	Phase 3
NCT03370601	University Hospital, Lille	Inflammatory Bowel Diseases	January 3, 2017	Not Applicable
NCT00036387	Centocor, Inc.	Arthritis, Rheumatoid		Phase 3
NCT05180994	Centre hospitalier de l´Université de Montréal (CHUM)\|Fonds de recherche en ophtalmologie de l´Université de Montréal\|Maisonneuve-Rosemont Hospital\|Niagara Health System\|Prism Eye Institute\|Ottawa Hospital Research Institute	Glaucoma Following Surgery	May 1, 2022	Phase 1\|Phase 2
NCT04879966	Sixth Affiliated Hospital, Sun Yat-sen University	Moderate to Severe Ulcerative Colitis	May 17, 2021
NCT01355614	Novartis Pharmaceuticals\|Novartis	Crohn´s Disease	June 2011	Phase 2
NCT00514982	National Institute of Allergy and Infectious Diseases (NIAID)\|National Institutes of Health Clinical Center (CC)	Hermanski-Pudlak Syndrome\|Colitis\|Cytokines\|Lymphocytes\|Drug Evaluation	August 7, 2007	Phase 2
NCT00574470	University of Iowa	Graft vs Host Disease	January 2006	Phase 4
NCT00432432	Chinese University of Hong Kong	Ankylosing Spondylitis	February 2005	Phase 4
NCT00244179	Charite University, Berlin, Germany\|dfg	Reactive Arthritis	January 2003	Phase 2
NCT04425538	Tufts Medical Center\|National Institutes of Health (NIH)	COVID-19	June 1, 2020	Phase 2
NCT02453776	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	Inflammatory Bowel Disease	May 2015	Phase 4
NCT00432406	Chinese University of Hong Kong	Psoriatic Arthritis	May 2006	Phase 4
NCT03765450	Alimentiv Inc.	Ulcerative Colitis	December 21, 2018
NCT03452501	Hikma Pharmaceuticals LLC	Inflammatory Bowel Diseases\|Crohn Disease\|Fistulizing Crohn´s Disease\|Ulcerative Colitis	August 26, 2018
NCT00725296	Merck Sharp & Dohme LLC\|Centocor, Inc.	Arthritis, Psoriatic	December 2004
NCT00202852	Merck Sharp & Dohme LLC	Arthritis, Rheumatoid	June 1, 2005	Phase 3
NCT00851565	Copenhagen University Hospital at Herlev\|Aase and Ejnar Danielsens Foundation\|Beckett Foundation\|the Danish Biotechnology Program\|Colitis-Crohn Foreningen\|Danish Medical Association\|Frode V. Nyegaard and wife´s Foundation\|Health Science Research Foundation of Region of Copenhagen\|Herlev Hospital Research Council\|Lundbeck Foundation\|P. Carl Petersens Fund\|Biomonitor A+S\|Prometheus Inc.\|The Danish Institute for Health Services Research	Crohn´s Disease	June 2009	Phase 4
NCT00507403	University Hospital, Tours\|Institut National de la Santé Et de la Recherche Médicale, France	Ankylosing Spondylitis	October 2007	Phase 4
NCT00230529	Centocor, Inc.	Psoriasis		Phase 2
NCT02148640	Diakonhjemmet Hospital\|South-Eastern Norway Regional Health Authority	Rheumatoid Arthritis\|Spondyloarthritis\|Psoriatic Arthritis\|Ulcerative Colitis\|Crohn´s Disease\|Psoriasis Chronic	October 2014	Phase 4
NCT03704363	Oslo University Hospital\|Haukeland University Hospital\|St. Olavs Hospital\|University Hospital of North Norway\|Vestre Viken Hospital Trust\|Ostfold Hospital Trust\|Clinical Trial Unit (CTU), Oslo University Hospital\|Diakonhjemmet Hospital	Low Back Pain	December 12, 2018	Phase 3
NCT00687401	Merck Sharp & Dohme LLC\|Centocor, Inc.	Psoriasis	June 2006	Phase 3
NCT02539368	Pfizer\|Hospira, now a wholly owned subsidiary of Pfizer	Inflammatory Bowel Diseases\|Ulcerative Colitis\|Crohn´s Disease	April 22, 2015
NCT01256489	Massachusetts Eye and Ear Infirmary	Stevens-Johnson Syndrome\|Corneal Blindness	December 2010	Phase 1\|Phase 2
NCT04898231	University of California, San Diego\|Children´s Hospital of Michigan\|The Children´s Foundation	Multisystem Inflammatory Syndrome-Children	December 22, 2020	Phase 2\|Phase 3
NCT05291039	Rehab Werida\|Damanhour University	Irritable Bowel Disease	January 1, 2022	Not Applicable
NCT00823641	Imperial College London\|Medical Research Council	HTLV-I-associated Myelopathy	October 2008	Phase 2
NCT02878161	Fen Li\|Central South University	Rheumatoid Arthritis	January 2016	Phase 4
NCT00029042	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|National Institutes of Health Clinical Center (CC)	Juvenile Rheumatoid Arthritis	January 2002	Phase 2
NCT04921670	Cares, Kristen, M.D.	Inflammatory Bone Disease	March 12, 2021
NCT01571206	Celltrion	Ankylosing Spondylitis	March 2012	Phase 1
NCT02177071	Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives\|Saint-Louis Hospital, Paris, France	Crohn´s Disease	October 9, 2015	Phase 4
NCT04438382	ECOG-ACRIN Cancer Research Group\|National Cancer Institute (NCI)\|Eastern Cooperative Oncology Group	Hematopoietic and Lymphoid Cell Neoplasm\|Malignant Solid Neoplasm\|Steroid-Refractory Pneumonitis	January 7, 2021	Phase 2
NCT00779012	Merck Sharp & Dohme LLC	Spondylitis, Ankylosing	October 1, 2004	Phase 4
NCT00542152	Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives	Ulcerative Colitis\|Steroid Refractory	June 2007	Phase 4
NCT04407247	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Colitis\|Lung Non-Small Cell Carcinoma\|Malignant Genitourinary System Neoplasm\|Malignant Solid Neoplasm\|Melanoma	July 9, 2020	Phase 1\|Phase 2
NCT00705289	Merck Sharp & Dohme LLC	Rheumatoid Arthritis	December 2005
NCT03684278	Professor Robert Sutton\|Liverpool Clinical Trials Centre\|Bangor University\|University of Liverpool\|Liverpool University Hospitals NHS Foundation Trust\|Medical Research Council\|National Institute for Health Research, United Kingdom\|Merck Sharp & Dohme LLC	Acute Pancreatitis	May 1, 2019	Phase 2
NCT00462072	University of Rochester\|Centocor, Inc.	Rheumatoid Arthritis\|Psoriatic Arthritis\|Psoriasis\|Crohn´s Disease	March 2007	Phase 4
NCT00705471	Merck Sharp & Dohme LLC\|Centocor, Inc.	Crohn Disease	April 2005
NCT03293784	Institut Claudius Regaud	Melanoma	October 16, 2017	Phase 1
NCT04610476	University of Erlangen-Nürnberg Medical School	Psoriatic Arthritis\|Withdrawal\|Reduction	October 19, 2020	Phase 3
NCT00207701	Centocor, Inc.\|Centocor BV	Ankylosing Spondylitis	September 2002	Phase 3
NCT00358670	Merck Sharp & Dohme LLC	Psoriasis	May 2006	Phase 3
NCT03596645	Janssen Research & Development, LLC	Colitis, Ulcerative	October 29, 2018	Phase 3
NCT00372723	Loyola University	Toxic Epidermal Necrolysis	July 2006	Phase 2
NCT02136069	Hoffmann-La Roche	Ulcerative Colitis	December 24, 2014	Phase 3
NCT04982172	Universitaire Ziekenhuizen KU Leuven\|KU Leuven	Inflammatory Bowel Diseases	February 2022	Phase 4
NCT03679546	Rennes University Hospital	Ulcerative Colitis	January 4, 2019	Phase 4
NCT00269854	Centocor, Inc.	Crohn Disease	June 1995	Phase 2\|Phase 3
NCT02770040	Austin Health\|University of Melbourne	Ulcerative Colitis	July 2016	Phase 4
NCT00936143	Gu Jieruo\|Sun Yat-sen University	Spondylitis	January 2008	Phase 4
NCT00589628	Egla C. Rabinovich\|Childhood Arthritis and Rheumatology Research Alliance\|Duke University	Chronic Uveitis	September 2007	Phase 4
NCT01551290	Xian-Janssen Pharmaceutical Ltd.	Ulcerative Colitis	April 2012	Phase 3
NCT00748826	Merck Sharp & Dohme LLC	Arthritis, Rheumatoid	August 2002
NCT01485055	Nationwide Children´s Hospital	Graft Versus Host Disease\|Steroid Refractory GVHD\|Acute GVH Disease	December 2011	Phase 2
NCT05379049	University of Sulaimani	Rheumatoid Arthritis\|Inflammatory Arthritis\|Ankylosing Spondylitis	March 1, 2022
NCT03112603	Incyte Corporation	Graft-versus-host Disease (GVHD)	March 7, 2018	Phase 3
NCT01233583	University of Aberdeen\|NHS Grampian	Psoriasis	June 2010
NCT00237419	Rheumazentrum Ruhrgebiet\|Centocor BV\|Trial Coordination Center, 9713 GZ Groningen\|PPD	Ankylosing Spondylitis	December 2005	Not Applicable
NCT04775732	Imelda GI Clinical Research Center	Crohn Disease\|Ulcerative Colitis	June 1, 2018	Phase 4
NCT00216177	Hvidovre University Hospital\|University Hospital, Gentofte, Copenhagen	Rheumatoid Arthritis	September 2005	Phase 4
NCT05280405	IRCCS Burlo Garofolo	Inflammatory Bowel Diseases	March 9, 2022	Phase 4
NCT01217086	Celltrion	Rheumatoid Arthritis	October 2010	Phase 3
NCT02363738	University Health Network, Toronto\|Clinical Investigation Centre for Innovative Technology Network\|Stanford University	Bipolar Depression	September 2015	Phase 2
NCT02566889	Janssen Scientific Affairs, LLC	Inflammatory Bowel Diseases	April 2016	Phase 4
NCT00236028	Centocor, Inc.	Rheumatoid Arthritis		Phase 3
NCT03885037	Pfizer	Rheumatoid Arthritis	March 20, 2019
NCT03088293	Hospices Civils de Lyon	Idiopathic Refractory Scleritis	June 11, 2020	Phase 3
NCT03100253	Mario Negri Institute for Pharmacological Research	Rheumatoid Arthritis	March 1, 2018	Phase 4
NCT03884439	Pfizer	Crohn´s Disease\|Ulcerative Colitis	March 18, 2019
NCT01571219	Celltrion	Rheumatoid Arthritis	March 2012	Phase 3
NCT02322008	Regionshospitalet Viborg, Skive	Crohn´s Disease\|Ulcerative Colitis\|Inflammatory Bowel Disease	September 2009
NCT00056264	Centocor, Inc.	Chronic Obstructive Pulmonary Disease\|COPD	December 2002	Phase 3
NCT01442025	Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives	Crohn´s Disease	June 2012	Phase 4
NCT01148901	Merck Sharp & Dohme LLC\|Hospital Universitario Reina Sofia de Cordoba\|Dr. Jose María Martos Becerra (Central Radiological Assessment) - Hospital de Alta Resolución, Puente Genil (Spain)	Ankylosing Spondylitis	June 2010	Phase 4
NCT00796250	Merck Sharp & Dohme LLC	Crohn´s Disease	November 1, 2003	Phase 3
NCT01559142	Children´s Memorial Health Institute, Poland	Crohn Disease	November 2008	Phase 3
NCT00752622	Merck Sharp & Dohme LLC	Crohn´s Disease	November 2008	Phase 4
NCT00714493	Centocor Ortho Biotech Services, L.L.C.\|Schering-Plough	Rheumatoid Arthritis	July 2008	Phase 4
NCT03016260	TcLand Expression S.A.\|European Commission	RheumatoId Arthritis	December 2016
NCT00246064	Centocor Ortho Biotech Services, L.L.C.	Arthritis, Rheumatoid	December 2001	Phase 4
NCT01793519	Georgetown University\|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|University of Maryland, College Park\|Washington D.C. Veterans Affairs Medical Center\|Medstar Health Research Institute\|Patient-Centered Outcomes Research Institute\|Arthritis and Pain Associates of PG County\|Arthritis & Rheumatism Associates, P.C.\|Rheumatology Associates of Baltimore, L.L.C.\|The Arthritis Clinic of Northern Virginia, P.C.\|Arthritis and Rheumatic Disease Associates, P.C.	Rheumatoid Arthritis	January 2013	Phase 4
NCT00732875	Merck Sharp & Dohme LLC	Arthritis, Rheumatoid	August 2006	Phase 3
NCT00367237	Merck Sharp & Dohme LLC\|Integrated Therapeutics Group	Arthritis, Psoriatic	May 2006	Phase 3
NCT03348046	Hikma Pharmaceuticals LLC\|Syneos Health	Rheumatoid Arthritis	March 23, 2017
NCT02505568	Janssen Korea, Ltd., Korea	Behcet Disease	July 22, 2015	Phase 3
NCT01592292	Hoffmann-La Roche	Rheumatoid Arthritis	November 2011
NCT03358693	Prof. Dr. Stephan Weidinger\|University Hospital Schleswig-Holstein	Atopic Dermatitis\|Psoriasis	January 20, 2017
NCT00833053	Merck Sharp & Dohme LLC	Psoriasis	October 2009	Phase 3
NCT00818272	Merck Sharp & Dohme LLC\|Centocor, Inc.	Crohn´s Disease	December 2002
NCT03221166	IRCCS Burlo Garofolo\|Centro di Riferimento Oncologico - Aviano\|Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia	Crohn Disease	February 27, 2018	Phase 3
NCT03393247	Sixth Affiliated Hospital, Sun Yat-sen University	Crohn Disease	June 1, 2017	Not Applicable
NCT05584228	Nantes University Hospital\|Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives	Crohn Disease	April 1, 2023	Not Applicable
NCT04891991	Cairo University	Rhegmatogenous Retinal Detachment\|Proliferative Vitreoretinopathy\|Retinal Detachment	November 26, 2021	Phase 2
NCT04761952	Sixth Affiliated Hospital, Sun Yat-sen University	Inflammatory Bowel Diseases\|Crohn Disease\|Polyunsaturated Acid Lipidosis	February 13, 2021	Not Applicable
NCT00727298	Merck Sharp & Dohme LLC\|Centocor, Inc.	Arthritis, Rheumatoid\|Spondylitis, Ankylosing\|Arthritis, Psoriatic\|Psoriasis\|Crohn´s Disease	February 2006
NCT00133315	Hvidovre University Hospital	Spondylarthropathies\|Ankylosing Spondylitis\|Psoriatic Arthritis	September 2004	Phase 4
NCT00463580	Emory University\|National Institute of Mental Health (NIMH)	Depression	December 2008	Phase 4
NCT00527072	Centocor Ortho Biotech Services, L.L.C.	Psoriasis	July 2007	Phase 3
NCT02771457	NYU Langone Health	Inflammatory Bowel Disease	July 2016	Phase 3
NCT02359903	Biocad	Ankylosing Spondylitis	February 2015	Phase 1
NCT03371095	Assistance Publique - Hôpitaux de Paris	Behcet´s Disease\|Vasculitis	March 15, 2018	Phase 3
NCT00040885	Alliance for Clinical Trials in Oncology\|National Cancer Institute (NCI)	Anorexia\|Cachexia\|Fatigue\|Lung Cancer	October 2002	Phase 3
NCT00396747	Université Catholique de Louvain	Rheumatoid Arthritis	June 2003	Phase 4
NCT05386290	Peking Union Medical College Hospital	Ulcerative Colitis\|Crohn Disease	July 9, 2020
NCT05340764	Washington University School of Medicine	Inflammatory Bowel Diseases	August 1, 2020	Phase 4
NCT03937609	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)\|Pfizer	Colitis, Ulcerative	September 4, 2019	Phase 4
NCT00984568	Merck Sharp & Dohme LLC	Colitis, Ulcerative	November 2009	Phase 3
NCT00394589	Merck Sharp & Dohme LLC\|Integrated Therapeutics Group	Rheumatoid Arthritis	March 2006	Phase 3
NCT01567358	Nichi-Iko Pharmaceutical Co., Ltd.	Rheumatoid Arthritis	February 2012	Phase 1
NCT00207688	Janssen Research & Development, LLC\|Janssen Biologics BV	Ulcerative Colitis	August 31, 2004
NCT03819296	M.D. Anderson Cancer Center\|National Cancer Institute (NCI)	Clinical Stage 0 Cutaneous Melanoma AJCC v8\|Clinical Stage I Cutaneous Melanoma AJCC v8\|Clinical Stage IA Cutaneous Melanoma AJCC v8\|Clinical Stage IB Cutaneous Melanoma AJCC v8\|Clinical Stage II Cutaneous Melanoma AJCC v8\|Clinical Stage IIA Cutaneous Melanoma AJCC v8\|Clinical Stage IIB Cutaneous Melanoma AJCC v8\|Clinical Stage IIC Cutaneous Melanoma AJCC v8\|Clinical Stage III Cutaneous Melanoma AJCC v8\|Clinical Stage IV Cutaneous Melanoma AJCC v8\|Colitis\|Lung Non-Small Cell Carcinoma\|Malignant Genitourinary System Neoplasm\|Malignant Solid Neoplasm\|Pathologic Stage 0 Cutaneous Melanoma AJCC v8\|Pathologic Stage I Cutaneous Melanoma AJCC v8\|Pathologic Stage IA Cutaneous Melanoma AJCC v8\|Pathologic Stage IB Cutaneous Melanoma AJCC v8\|Pathologic Stage II Cutaneous Melanoma AJCC v8\|Pathologic Stage IIA Cutaneous Melanoma AJCC v8\|Pathologic Stage IIB Cutaneous Melanoma AJCC v8\|Pathologic Stage IIC Cutaneous Melanoma AJCC v8\|Pathologic Stage III Cutaneous Melanoma AJCC v8\|Pathologic Stage IIIA Cutaneous Melanoma AJCC v8\|Pathologic Stage IIIB Cutaneous Melanoma AJCC v8\|Pathologic Stage IIIC Cutaneous Melanoma AJCC v8\|Pathologic Stage IIID Cutaneous Melanoma AJCC v8\|Pathologic Stage IV Cutaneous Melanoma AJCC v8\|Stage 0 Lung Cancer AJCC v8\|Stage I Lung Cancer AJCC v8\|Stage IA1 Lung Cancer AJCC v8\|Stage IA2 Lung Cancer AJCC v8\|Stage IA3 Lung Cancer AJCC v8\|Stage IB Lung Cancer AJCC v8\|Stage II Lung Cancer AJCC v8\|Stage IIA Lung Cancer AJCC v8\|Stage IIB Lung Cancer AJCC v8\|Stage III Lung Cancer AJCC v8\|Stage IIIA Lung Cancer AJCC v8\|Stage IIIB Lung Cancer AJCC v8\|Stage IIIC Lung Cancer AJCC v8\|Stage IV Lung Cancer AJCC v8\|Stage IVA Lung Cancer AJCC v8\|Stage IVB Lung Cancer AJCC v8	February 21, 2021	Phase 1\|Phase 2
NCT02517684	Erasmus Medical Center\|ZonMw: The Netherlands Organisation for Health Research and Development\|Hospira, now a wholly owned subsidiary of Pfizer	Crohn´s Disease	April 2015	Phase 4
NCT04150770	Xiaomin Zhang\|Tianjin Medical University	Uveitis\|Infliximab	January 2017	Phase 4
NCT00753103	University Hospital Birmingham NHS Foundation Trust	Wegener´s Granulomatosis\|Renal Limited Vasculitis\|Microscopic Polyangiitis	January 2003	Phase 2
NCT00591201	Hospital General de Mexico\|Schering-Plough	Spondylarthropathies	June 2002	Phase 2\|Phase 3
NCT00688636	University of Pittsburgh\|Centocor, Inc.	Crohn´s Disease	January 2005	Phase 4
NCT00686595	Merck Sharp & Dohme LLC\|Centocor, Inc.	Psoriasis	October 2007	Phase 4
NCT00207766	Centocor, Inc.	Crohn Disease	June 2000	Phase 3
NCT00094458	Centocor Ortho Biotech Services, L.L.C.\|Schering-Plough	Crohn Disease	March 2005	Phase 3
NCT00033891	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|National Institutes of Health Clinical Center (CC)	Dermatomyositis\|Polymyositis	April 10, 2002	Phase 2
NCT01817426	Copenhagen University Hospital at Herlev	Crohn Disease	January 2013	Phase 4
NCT01931189	Nichi-Iko Pharmaceutical Co., Ltd.	Healthy	August 2013	Phase 1
NCT04530877	Children´s Hospital of Fudan University	Crohn´s Disease\|Exclusive Enteral Nutrition\|Infliximab\|Mucosal Healing	October 1, 2022	Phase 4
NCT00724672	Merck Sharp & Dohme LLC	Rheumatoid Arthritis	September 2008
NCT02251041	Universitaire Ziekenhuizen KU Leuven	Reperfusion Injury	September 2014	Phase 2
NCT00808210	Genentech, Inc.	Rheumatoid Arthritis	March 5, 2009	Phase 2
NCT05034536	Massachusetts General Hospital\|Massachusetts Institute of Technology	Metastatic Melanoma	February 7, 2022	Phase 2
NCT01245361	Patrick Durez\|Université Catholique de Louvain	Undifferentiated Arthritis	November 2007	Not Applicable
NCT00304954	National Eye Institute (NEI)\|National Institutes of Health Clinical Center (CC)	Age-Related Macular Degeneration\|Choroidal Neovascularization	February 2006	Phase 2
NCT00269841	Centocor, Inc.	Crohn Disease	May 1996	Phase 3
NCT04999228	Children´s Hospital of Fudan University	Ulcerative Colitis\|Infliximab\|Children	November 1, 2021	Phase 4
NCT02990806	Nichi-Iko Pharmaceutical Co., Ltd.	Rheumatoid Arthritis (RA)	December 2016	Phase 3
NCT00207662	Centocor, Inc.	Crohn Disease	July 2000	Phase 3
NCT00791557	University Hospitals Cleveland Medical Center\|Centocor, Inc.	Pyoderma Gangrenosum\|Crohn´s Disease\|Ulcerative Colitis\|Inflammatory Bowel Disease	October 2008	Not Applicable
NCT03704610	Assistance Publique - Hôpitaux de Paris	Extrathoracic Sarcoidosis	March 28, 2019	Phase 3
NCT00725452	Merck Sharp & Dohme LLC\|Centocor, Inc.	Psoriasis	October 2006
NCT03151525	Istituto Clinico Humanitas\|Agenzia Italiana del Farmaco	Colitis, Ulcerative	May 8, 2017	Phase 4
NCT01308255	University of Leeds	Rheumatoid Arthritis	September 2006	Phase 4
NCT00283712	National Institute of Allergy and Infectious Diseases (NIAID)\|Autoimmunity Centers of Excellence	Pemphigus	March 2006	Phase 2
NCT00252369	Sheba Medical Center	Crohn´s Disease		Not Applicable
NCT01266785	Oregon Health and Science University\|Centocor, Inc.	Crohn´s Disease	December 2010	Not Applicable
NCT00725621	Merck Sharp & Dohme LLC\|Centocor, Inc.	Rheumatoid Arthritis	March 2004
NCT00336492	Centocor, Inc.	Ulcerative Colitis	September 2006	Phase 3
NCT00251641	Merck Sharp & Dohme LLC	Psoriasis	September 1, 2005	Phase 3
NCT02453607	Ernest Seidman\|University of Toronto\|University of Calgary\|University of Alberta\|McGill University Health Centre+Research Institute of the McGill University Health Centre	Inflammatory Bowel Disease\|Crohn´s Disease	November 17, 2014
NCT03006393	Emory University\|National Institute of Mental Health (NIMH)	Depression	August 2016	Phase 4
NCT01313520	Merck Sharp & Dohme LLC	Arthritis, Rheumatoid	March 1, 2011	Phase 2
NCT00076726	Centocor, Inc.\|The Cleveland Clinic	Giant Cell Arteritis	November 2003	Phase 2
NCT00523354	Swiss EE Study Group	Esophagitis	August 2007	Phase 2
NCT00724958	Merck Sharp & Dohme LLC\|Centocor, Inc.	Crohn´s Disease	December 2004
NCT01661257	Samsung Medical Center	Crohn´s Disease	October 2009	Phase 3
NCT00521924	Merck Sharp & Dohme LLC\|AESCA Pharma GmbH	Rheumatoid Arthritis	June 2007	Phase 3
NCT00818168	Merck Sharp & Dohme LLC\|Centocor, Inc.	Spondylitis, Ankylosing	July 2003
NCT00686686	Merck Sharp & Dohme LLC\|Centocor, Inc.	Psoriasis	December 2007	Phase 3
NCT04535518	Children´s Hospital of Fudan University\|Shanghai Children´s Hospital\|Shanghai Children´s Medical Center\|Xinhua Hospital, Shanghai Jiao Tong University School of Medicine\|Shanghai 10th People´s Hospital	Kawasaki Disease	October 2020	Phase 3
NCT01812954	Jochen Schmitt.\|Merck Sharp & Dohme LLC\|Technische Universität Dresden	Psoriasis	March 2013
NCT00201799	Ohio State University Comprehensive Cancer Center	Graft-Versus-Host Disease	February 2004	Phase 2
NCT01927263	Nichi-Iko Pharmaceutical Co., Ltd.	Rheumatoid Arthritis	July 2013	Phase 3
NCT00207714	Centocor, Inc.\|Centocor BV	Rheumatoid Arthritis	November 2003	Phase 2
NCT00254982	Merck Sharp & Dohme LLC\|Essex Pharma GmbH\|Centocor, Inc.	Psoriasis	August 2005	Phase 3
NCT02847884	University of Alberta\|The Hospital for Sick Children\|The Children´s Hospital of Winnipeg\|Alberta Children´s Hospital\|Provincial Health Services Authority\|Children´s Hospital of Eastern Ontario	Inflammatory Bowel Disease\|Crohn´s Disease	October 2015
NCT03147248	Celltrion	Rheumatoid Arthritis	September 12, 2016	Phase 3
NCT04655729	Massachusetts General Hospital\|Crohn´s & Colitis Foundation	Crohn Disease	November 18, 2019
NCT00636142	Medical University of Graz	Obesity\|Insulin Resistance\|Metabolic Syndrome	September 2005	Phase 4
NCT00629772	Innovaderm Research Inc.\|Schering-Plough	Palmoplantar Psoriasis	March 2007	Phase 3
NCT04131504	Children´s Hospital Medical Center, Cincinnati\|The Leona M. and Harry B. Helmsley Charitable Trust	Crohn´s Disease\|IBD	October 16, 2019
NCT00908089	University of Helsinki\|Seinajoki Central Hospital\|Oulu University Hospital\|Jyväskylä Central Hospital\|Kuopio University Hospital\|Satakunta Central Hospital\|University of Turku\|Rheumatism Foundation Hospital\|Orton Invalid Foundation\|South Carelia Central Hospital\|Lappi Central Hospital\|Kanta-Häme Central Hospital	Rheumatoid Arthritis	March 2003	Phase 4
NCT01706692	Swiss Dermatology Network for Targeted Therapies	Psoriasis	July 2011
NCT00958906	Icahn School of Medicine at Mount Sinai	Uveitic Macular Edema\|Intraocular Inflammation	August 2009	Phase 1\|Phase 2
NCT02994836	Fundación de Investigación Biomédica - Hospital Universitario de La Princesa	Crohn´s Disease\|Inflammatory Bowel Disease\|Ulcerative Colitis	April 21, 2017	Phase 4
NCT02060318	Hvidovre University Hospital	Crohn Disease	February 11, 2014
NCT04990258	Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives\|Celltrion	Inflammatory Bowel Diseases	September 6, 2021
NCT03445624	Assiut University	Inflammatory Bowel Diseases	July 1, 2018
NCT02987686	Centre hospitalier de l´Université de Montréal (CHUM)\|Fonds de recherche en ophtalmologie de l´Université de Montréal	Sterile Corneal Melt	September 6, 2017	Phase 1
NCT03192878	Ospedale San Raffaele	Takayasu Arteritis	March 1, 2017
NCT01144143	Herbert Lindsley, MD\|Centocor, Inc.\|University of Kansas Medical Center	Osteoarthritis of the Knee	July 2007	Phase 4
NCT00202865	Merck Sharp & Dohme LLC	Spondylitis, Ankylosing	May 1, 2005	Phase 3
NCT01216631	University of Leeds\|Centocor, Inc.	Spondylarthropathies	September 2010	Phase 2
NCT02096861	Celltrion\|Pfizer	Crohn´s Disease	September 19, 2014	Phase 3
NCT00074074	European Organisation for Research and Treatment of Cancer - EORTC	Myelodysplastic Syndromes	October 2003	Phase 2
NCT01915537	Zhang, Xiao, M.D.\|Central South University\|Tianjin Medical University General Hospital\|Xijing Hospital	Rheumatoid Arthritis?RA?	August 2013	Not Applicable
NCT04305145	Massachusetts General Hospital	Melanoma Stage III\|Melanoma Stage IV\|Side Effect of Drug\|Colitis	August 31, 2020	Phase 2
NCT00273390	Oregon Health and Science University\|Centocor, Inc.	Uveitis	August 2001	Not Applicable
NCT00325078	National Institute of Allergy and Infectious Diseases (NIAID)\|National Institutes of Health Clinical Center (CC)	Chronic Granulomatous Disease\|Crohn´S-like IBD\|Inflammatory Bowel Disease (IBD)	May 2006	Phase 1\|Phase 2
NCT00749398	Merck Sharp & Dohme LLC	Psoriasis	September 2007
NCT02883452	Celltrion	Crohn´s Disease\|Ulcerative Colitis (Part 2 Only)	September 29, 2016	Phase 1
NCT01880307	Erasmus Medical Center\|University of Roma La Sapienza\|Universitair Ziekenhuis Brussel	Crohn´s Disease	January 2013	Phase 4
NCT04725422	Seattle Children´s Hospital\|Boston Children´s Hospital, Boston, MA, USA\|Hospital for Special Surgery, New York City, NY, USA\|Joseph M Sanzari Children´s Hospital, Hackensack University Medical Center, Hackensack, NJ, USA\|Riley Children´s Hospital, Indianapolis, IN, USA\|University of North Carolina, Chapel Hill, NC, USA\|Royal Children´s Hospital, Melbourne, Australia\|Hacettepe University, Ankara, Turkey\|Bambino Gesù Children´s Hospital, Rome, Italy\|University of British Columbia, Vancouver, BC, Canada\|Meyer Children´s Hospital, Florence, Italy\|Mansoura University	Chronic Nonbacterial Osteomyelitis\|Chronic Recurrent Multifocal Osteomyelitis	August 1, 2018
NCT03209232	Schneider Children´s Medical Center, Israel	Ulcerative Colitis	April 16, 2018	Not Applicable
NCT00036374	Centocor, Inc.	Rheumatoid Arthritis, Juvenile	October 2001	Phase 3
NCT00724243	Merck Sharp & Dohme LLC	Rheumatoid Arthritis	January 2006
NCT04505410	University of Miami\|Pfizer	Ulcerative Colitis	November 18, 2020	Phase 3
NCT01177800	Xian-Janssen Pharmaceutical Ltd.	Psoriasis	February 2009	Phase 3
NCT00111917	Maier, Lisa, M.D.\|Centocor, Inc.\|National Center for Research Resources (NCRR)	Berylliosis\|Beryllium Disease	February 2005	Phase 1\|Phase 2
NCT03446976	Celltrion	Health, Subjective	February 21, 2018	Phase 1
NCT05552287	Erasmus Medical Center	Crohn Disease\|Child, Only\|Biologic; Inadequate	November 2022	Phase 4
NCT02605642	Pfizer\|Hospira, now a wholly owned subsidiary of Pfizer	Rheumatoid Diseases\|Rheumatoid Arthritis\|Ankylosing Spondylitis\|Psoriatic Arthritis	September 10, 2015
NCT01850121	Göteborg University	Ankylosing Spondylitis	January 2003
NCT02728934	Janssen Scientific Affairs, LLC	Arthritis, Rheumatoid	February 25, 2016
NCT00687362	Merck Sharp & Dohme LLC	Psoriasis	May 30, 2006	Phase 2
NCT03885089	Pfizer	Psoriasis Vulgaris\|Psoriasis Arthropathica\|Pustular Psoriasis\|Erythrodermic Psoriasis	October 21, 2019
NCT03065244	University of California, San Diego\|Patient-Centered Outcomes Research Institute	Mucocutaneous Lymph Node Syndrome	February 17, 2017	Phase 3
NCT05043870	Children´s Hospital of Fudan University	Crohn Disease\|Infliximab\|Immunosuppression\|Children, Only	October 10, 2022	Phase 4
NCT02126020	James Chodosh, MD, MPH\|Massachusetts Eye and Ear Infirmary\|Fonds de recherche en ophtalmologie de l´Université de Montréal	Stevens-Johnson Syndrome\|Toxic Epidermal Necrolysis (Lyell) Syndrome\|Mucous Membrane Pemphigoid	November 2014	Phase 1\|Phase 2
NCT01237262	University of Padova	Moderate to Severe Psoriasis.\|Absolute Number, Density of Immune Infiltrate and Dendritic Cells and Inflammatory Cytokines Expression Pattern.	November 2010	Phase 4
NCT03308357	The Alfred\|Merck Sharp & Dohme LLC	Inflammatory Bowel Diseases	October 2017
NCT01282528	Peking Union Medical College Hospital\|Shanghai Changzheng Hospital\|First Hospital of China Medical University\|Shenzhen People´s Hospital\|Changhai Hospital\|First Affiliated Hospital of Wenzhou Medical University\|First People´s Hospital of Foshan\|West China Hospital	Rheumatoid Arthritis\|Ultrasonography\|Infliximab	September 2010	Phase 4
NCT00368264	Medical University of Vienna\|Hospital Hietzing\|Medical University of Graz\|Charite University, Berlin, Germany\|University of Erlangen-Nürnberg\|Heinrich-Heine University, Duesseldorf\|University Medical Center Groningen\|Leiden University Medical Center\|Radboud University Medical Center	Lupus Erythematosus, Systemic\|Lupus Nephritis	September 2006	Phase 2\|Phase 3
NCT00505947	University of Athens	Diabetic Macular Edema\|Visual Acuity\|Diabetic Retinopathy	July 2007	Phase 3
NCT05072782	Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives\|Celltrion	Crohn Disease	December 21, 2021	Phase 4
NCT04272788	Second Affiliated Hospital of Wenzhou Medical University	Crohn Disease	January 24, 2017
NCT00695682	Retina Research Foundation	Diabetic Retinopathy\|Macular Degeneration	June 2008	Phase 1
NCT00175266	University of Alberta\|Juvenile Diabetes Research Foundation	Type 1 Diabetes		Phase 2
NCT00073437	Centocor, Inc.	Sarcoidosis	October 2003	Phase 3
NCT01971814	University of California, San Francisco	Ulcerative Colitis (UC)\|Inflammatory Bowel Disease	November 2013	Phase 1
NCT03004443	Emory University\|National Institute of Mental Health (NIMH)	Depression	May 15, 2017	Phase 4
NCT02694588	University Hospital Schleswig-Holstein	IBD	June 2014	Not Applicable
NCT05313620	Fundación de Investigación Biomédica - Hospital Universitario de La Princesa	Ulcerative Colitis\|Thromboembolism	April 1, 2022	Phase 4
NCT00512278	Nizar Zein\|Centocor, Inc.\|The Cleveland Clinic	Hepatitis C	July 2007	Phase 2
NCT00779675	Merck Sharp & Dohme LLC	Psoriasis	October 2008
NCT00794898	Merck Sharp & Dohme LLC	Arthritis, Rheumatoid	July 1, 2003	Phase 4
NCT03885713	Fundación de Investigación Biomédica - Hospital Universitario de La Princesa	Inflammatory Bowel Diseases\|Crohn Disease\|Ulcerative Colitis	September 10, 2019	Phase 4
NCT00896168	Xian-Janssen Pharmaceutical Ltd.	Arthritis, Rheumatoid	June 2007	Phase 4
NCT04564001	Assistance Publique - Hôpitaux de Paris	Takayasu Arteritis	September 2020	Phase 2
NCT00840957	University Hospital, Tours	Rheumatoid Arthritis	November 2007
NCT01971970	Erasmus Medical Center\|Merck Sharp & Dohme LLC	Inflammatory Bowel Diseases	October 2013
NCT03662919	Biogen	Arthritis, Rheumatoid\|Spondylitis, Ankylosing\|Arthritis, Psoriatic\|Crohn´s Disease\|Colitis, Ulcerative	July 2, 2018
NCT00006292	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)\|National Institutes of Health Clinical Center (CC)	Rheumatoid Arthritis	September 2000	Phase 2
NCT00106834	Centocor, Inc.	Psoriasis		Phase 3
NCT04922827	Jena University Hospital\|German Federal Ministry of Education and Research\|Celltrion	COVID-19	June 18, 2021	Phase 2
NCT00112749	Jonsson Comprehensive Cancer Center\|American Cancer Society, Inc.	Breast Cancer\|Fatigue	February 2005	Phase 2
NCT00844805	Merck Sharp & Dohme LLC	Ankylosing Spondylitis\|Axial Spondyloarthritis	September 2009	Phase 3
NCT05164198	Hanyang University Seoul Hospital\|Linical Korea	Ankylosing Spondylitis\|Axial Spondyloarthritis	January 15, 2022	Phase 4
NCT00725543	Merck Sharp & Dohme LLC\|Centocor, Inc.	Spondylitis, Ankylosing	June 2004
NCT01015547	Helsinki University Central Hospital\|Foundation for Paediatric Research, Finland\|Päivikki and Sakari Sohlberg Foundation, Finland\|Rheumatism Foundation Hospital\|Scandinavian Rheumatology Research Foundation\|Paijat-Hame Hospital District	Juvenile Idiopathic Arthritis	May 2003	Phase 3
NCT02495077	National Institute of Allergy and Infectious Diseases (NIAID)\|Clinical Trials in Organ Transplantation\|Rho Federal Systems Division, Inc.	Kidney Transplant	November 2, 2015	Phase 2
NCT04779892	Taizhou Mabtech Pharmaceutical Co.,Ltd	Rheumatoid Arthritis	February 1, 2020	Phase 1
NCT00106847	Centocor, Inc.	Psoriasis\|Parapsoriasis	January 2003	Phase 3
NCT02770794	Chiba University	Arthritis, Rheumatoid	April 1, 2016	Phase 4
NCT02522169	Klinikum Westbrandenburg GmbH	Pediatric Crohns Disease	September 2015	Not Applicable
NCT01936181	Samsung Bioepis Co., Ltd.	Rheumatoid Arthritis	August 2013	Phase 3
NCT00537316	Merck Sharp & Dohme LLC	Ulcerative Colitis	July 2007	Phase 3
NCT00901550	Chinese University of Hong Kong	Rheumatoid Arthritis	November 2008	Not Applicable
NCT02763761	Bristol-Myers Squibb	Renal Cell Carcinoma\|Melanoma\|Lung Cancer	August 16, 2016	Phase 2
NCT01181765	Janssen Inc.	Crohn´s Disease	June 2012	Phase 4
NCT00075075	National Eye Institute (NEI)\|National Institutes of Health Clinical Center (CC)	Scleritis	December 23, 2003	Phase 1
NCT03414502	University of Nebraska	Rheumatoid Arthritis	August 2007	Phase 3
NCT04835506	Beth Israel Deaconess Medical Center\|The Leona M. and Harry B. Helmsley Charitable Trust\|Icahn School of Medicine at Mount Sinai	Crohn Disease	November 1, 2021	Phase 4
NCT00307593	Assistance Publique - Hôpitaux de Paris	Wegener´s Granulomatosis\|Churg-Strauss Syndrome\|Microscopic Polyangiitis	May 2004	Not Applicable
NCT00741104	Merck Sharp & Dohme LLC	Rheumatoid Arthritis	January 2008
NCT02293681	Janssen Research & Development, LLC	Spondylitis, Ankylosing	April 10, 2015
NCT00604864	KU Leuven	Endometriosis	February 2004	Phase 2
NCT00244192	Center for Integrated Rehabilitation and Organ Failure Horn\|Centocor, Inc.	COPD\|Cachexia	October 2003	Phase 2
NCT04646187	University Medical Center Groningen\|European Crohn´s and Colitis Organisation\|Bühlmann Laboratories AG	Inflammatory Bowel Diseases\|Crohn Disease\|Colitis, Ulcerative	March 11, 2021	Phase 4
NCT02799615	Children´s Hospital Medical Center, Cincinnati\|Crohn´s and Colitis Foundation	Colitis, Ulcerative\|Bowel Diseases, Inflammatory	May 2016
NCT01408810	Grupo de Estudo da Doença Inflamatória Intestinal	Ulcerative Colitis	February 2011	Phase 4
NCT01423591	Hospital Universitario Marqués de Valdecilla\|Schering-Plough	Polymyalgia Rheumatica	June 2007	Phase 3
NCT00521963	HaEmek Medical Center, Israel\|Bnai Zion Medical Center\|Carmel Medical Center	Arthritis	March 2010	Phase 2\|Phase 3
NCT00269867	Centocor, Inc.	Rheumatoid Arthritis	March 1997	Phase 3
NCT04734678	Ain Shams University\|Misr International University	Covid19\|Cytokine Storm\|Corona Virus Infection	December 1, 2020
NCT02425852	Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives	Ulcerative Colitis	December 2016	Phase 4
NCT05051137	Karolinska Institutet\|Harvard Medical School (HMS and HSDM)	Rheumatoid Arthritis	January 12, 2006
NCT04312659	Johnson & Johnson (China) Investment Ltd.	Crohn Disease	July 15, 2020
NCT01349920	Merck Sharp & Dohme LLC	Crohn Disease	November 28, 2012
NCT02937701	Amgen	Arthritis, Rheumatoid	October 10, 2016	Phase 3
NCT00271570	University of California, San Diego\|Centocor, Inc.	Kawasaki Disease	April 2004	Phase 1
NCT00096655	Centocor, Inc.	Ulcerative Colitis	May 2002	Phase 3
NCT01610947	University Hospital, Montpellier	Spondyloarthritis	May 14, 2012	Not Applicable
NCT00439283	Association de Recherche Clinique en Rhumatologie	Ankylosing Spondylitis	April 2003	Phase 3
NCT01886443	Universitaire Ziekenhuizen KU Leuven	Reperfusion Injury	August 2013	Phase 1
NCT04205643	Celltrion	Ulcerative Colitis	September 2, 2020	Phase 3
NCT00095147	Bristol-Myers Squibb	Rheumatoid Arthritis	February 2005	Phase 3
NCT00686894	Merck Sharp & Dohme LLC\|Centocor, Inc.	Spondylitis, Ankylosing\|SpA	January 2008	Phase 4
NCT01190839	Janssen Biotech, Inc.	Crohn´s Disease	November 2010	Phase 3
NCT02298062	Fudan University\|Shanghai Children´s Medical Center\|Shanghai 10th People´s Hospital\|Shanghai 8th People´s Hospital\|Shanghai Xuhui Distrct Center Hospital	Kawasaki Disease	January 2013	Phase 3
NCT00051623	Centocor, Inc.	Arthritis, Psoriatic	May 2003	Phase 3
NCT01295151	Julia Brown\|University of Leeds	Rheumatoid Arthritis	August 2011	Phase 4
NCT00036439	Centocor, Inc.	Ulcerative Colitis	February 2002	Phase 3
NCT00897312	Vanderbilt-Ingram Cancer Center\|National Cancer Institute (NCI)	Melanoma	October 2006
NCT00760435	University of California, San Diego\|Nationwide Children´s Hospital	Kawasaki Disease	March 2009	Phase 3
NCT00705484	Merck Sharp & Dohme LLC\|Centocor, Inc.	Ulcerative Colitis	June 1, 2007
NCT01338740	University Hospital, Ghent\|Abbott	Crohn´s Disease	April 2011
NCT03945019	Celltrion	Crohn´s Disease	October 28, 2019	Phase 3
NCT05406934	Assiut University	Bowel Disease\|Inflammatory Bowel Diseases	June 5, 2022
NCT00959725	Icahn School of Medicine at Mount Sinai	Diabetic Macular Edema	August 2009	Phase 1\|Phase 2
NCT02638701	University of California, San Francisco	Aneurysm\|Stroke\|Vasculitis\|Tumor Necrosis Factor-alpha	July 1, 2018	Phase 1\|Phase 2
NCT02743390	University of Campinas, Brazil	Hypertension	March 2015	Phase 4
NCT00443222	Karolinska Institutet\|Schering-Plough\|Medical Research Council	Refractory Myositis		Phase 2\|Phase 3
NCT00213564	University Hospital, Rouen	Rheumatoid Arthritis	April 2003
NCT00724529	Janssen Korea, Ltd., Korea	Crohn´s Disease\|Ankylosing Spondylitis	June 2007
NCT05205603	Sixth Affiliated Hospital, Sun Yat-sen University	Ulcerative Colitis\|Efficacy, Self\|Biologics\|Mesalazine	January 15, 2022	Phase 4
NCT01804166	Janssen Scientific Affairs, LLC	Hepatosplenic T-Cell Lymphoma	March 21, 2013	Phase 4
NCT02222493	Pfizer	Rheumatoid Arthritis	August 26, 2014	Phase 3
NCT05168475	Cambridge University Hospitals NHS Foundation Trust	Giant Cell Arteritis\|Takayasu Arteritis\|Cogan Syndrome\|Relapsing Polychondritis\|Cryoglobulinemic Vasculitis\|IgA Vasculitis\|Polyarteritis Nodosa\|Cutaneous Polyarteritis Nodosa\|Primary Angiitis of Central Nervous System	July 14, 2021	Phase 2
NCT00988832	Merck Sharp & Dohme LLC	Crohn´s Disease	February 2010
NCT04593940	Daniel Benjamin\|National Center for Advancing Translational Sciences (NCATS)\|Biomedical Advanced Research and Development Authority\|Duke University	Covid19	October 15, 2020	Phase 3
NCT01220518	Celltrion	Ankylosing Spondylitis	October 2010	Phase 1
NCT00261976	Centocor, Inc.\|Centocor BV	Arthritis, Rheumatoid\|Crohn Disease\|Psoriasis	February 2002
NCT02132234	Jagiellonian University\|Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland	Rheumatoid Arthritis\|Psoriatic Arthritis\|Ankylosing Spondylitis\|Hypertension	June 2013	Phase 4
NCT05220280	Clinical Urology and Epidemiology Working Group\|University of Helsinki\|World Health Organization\|Helsinki University Central Hospital\|Hyvinkää Hospital\|Kanta-Häme Central Hospital\|Kuopio University Hospital\|City of Helsinki\|Oulu University Hospital\|Porvoo Hospital\|Seinajoki Central Hospital\|Mikkeli Central Hospital\|Tampere University Hospital	Covid19\|Coronavirus Disease 2019\|SARS-CoV-2 Acute Respiratory Disease	February 6, 2022	Phase 4
NCT04330690	Sunnybrook Health Sciences Centre\|AbbVie\|Apotex Inc.\|World Health Organization\|University of British Columbia\|Arch Biopartners Inc.	COVID-19	March 18, 2020	Phase 3
NCT00795574	Florida Academic Dermatology Centers	Hidradenitis Suppurativa	June 2005	Phase 2
NCT03707535	Celltrion	Rheumatoid Arthritis	November 12, 2018	Phase 3
NCT00571337	Groupe d´Etude Therapeutique des Affections Inflammatoires Digestives	Crohn Disease	December 2005	Phase 3
NCT02088944	Nanfang Hospital of Southern Medical University	Serological C Reactive Protein or Erythrocyte Sedimentation Rate	March 2014
NCT00228839	Emory University	Graft vs Host Disease		Phase 1

Appearance

Solid

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

References

Synonyms

Immunoglobulin G, anti-(human tumor necrosis factor) (human-mouse monoclonal cA2 heavy chain), disulfide with human-mouse monoclonal cA2 light chain, dimer

Infliximab

Avakine

Remicade